J.P. Kolb

941 total citations
29 papers, 792 citations indexed

About

J.P. Kolb is a scholar working on Immunology, Molecular Biology and Physiology. According to data from OpenAlex, J.P. Kolb has authored 29 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 8 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in J.P. Kolb's work include Nitric Oxide and Endothelin Effects (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Immune Response and Inflammation (5 papers). J.P. Kolb is often cited by papers focused on Nitric Oxide and Endothelin Effects (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Immune Response and Inflammation (5 papers). J.P. Kolb collaborates with scholars based in France, Switzerland and United States. J.P. Kolb's co-authors include Christian Billard, Bernard Dugas, Brigitte Bauvois, Claire Mathiot, J.‐D. FOURNERON, Claire Quiney, Nathalie Paul‐Eugène, J Dumont, Célia Salanoubat and C. Damais and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Biochemical Pharmacology.

In The Last Decade

J.P. Kolb

28 papers receiving 766 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.P. Kolb France 17 292 269 138 135 127 29 792
Deborah M. Finucane United States 7 917 3.1× 384 1.4× 111 0.8× 89 0.7× 42 0.3× 7 1.4k
Hebok Song South Korea 16 632 2.2× 122 0.5× 50 0.4× 88 0.7× 119 0.9× 22 1.0k
Ellen Herlaar United Kingdom 6 324 1.1× 228 0.8× 45 0.3× 75 0.6× 22 0.2× 8 699
G.J. Brunn United States 8 800 2.7× 214 0.8× 48 0.3× 75 0.6× 23 0.2× 8 1.1k
Sen Zhang China 11 795 2.7× 75 0.3× 125 0.9× 39 0.3× 93 0.7× 24 1.0k
Marie Paule Defresne Belgium 14 314 1.1× 170 0.6× 32 0.2× 44 0.3× 28 0.2× 32 689
Wei Du United States 21 919 3.1× 238 0.9× 70 0.5× 77 0.6× 56 0.4× 78 1.3k
Markus K. Muellner Austria 11 474 1.6× 65 0.2× 35 0.3× 83 0.6× 50 0.4× 15 833
María J. López‐Zabalza Spain 20 262 0.9× 154 0.6× 253 1.8× 86 0.6× 20 0.2× 45 980
Neil Beeharry United States 19 631 2.2× 85 0.3× 38 0.3× 103 0.8× 36 0.3× 46 1.0k

Countries citing papers authored by J.P. Kolb

Since Specialization
Citations

This map shows the geographic impact of J.P. Kolb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Kolb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Kolb more than expected).

Fields of papers citing papers by J.P. Kolb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.P. Kolb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Kolb. The network helps show where J.P. Kolb may publish in the future.

Co-authorship network of co-authors of J.P. Kolb

This figure shows the co-authorship network connecting the top 25 collaborators of J.P. Kolb. A scholar is included among the top collaborators of J.P. Kolb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.P. Kolb. J.P. Kolb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bauvois, Brigitte, Juliette Nguyen, R. Tang, Christian Billard, & J.P. Kolb. (2009). Types I and II interferons upregulate the costimulatory CD80 molecule in monocytes via interferon regulatory factor-1. Biochemical Pharmacology. 78(5). 514–522. 24 indexed citations
2.
Azébazé, Anatole Guy Blaise, Christian Billard, Anne‐Marie Faussat, et al.. (2008). Apoptotic effects on B-cell chronic lymphocytic leukemia (B-CLL) cells of heterocyclic compounds isolated from Guttiferaes. Leukemia Research. 32(12). 1914–1926. 23 indexed citations
3.
Quiney, Claire, Christian Billard, A M Faussat, et al.. (2006). Pro-apoptotic properties of hyperforin in leukemic cells from patients with B-cell chronic lymphocytic leukemia. Leukemia. 20(3). 491–497. 43 indexed citations
4.
Quiney, Claire, Christian Billard, Célia Salanoubat, J.‐D. FOURNERON, & J.P. Kolb. (2006). Hyperforin, a new lead compound against the progression of cancer and leukemia?. Leukemia. 20(9). 1519–1525. 62 indexed citations
5.
Quiney, Claire, Christian Billard, P. Mirshahi, J.‐D. FOURNERON, & J.P. Kolb. (2006). Hyperforin inhibits MMP-9 secretion by B-CLL cells and microtubule formation by endothelial cells. Leukemia. 20(4). 583–589. 36 indexed citations
7.
Bauvois, Brigitte, J Dumont, Claire Mathiot, & J.P. Kolb. (2002). Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons. Leukemia. 16(5). 791–798. 88 indexed citations
8.
Kolb, J.P.. (2000). Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia. Leukemia. 14(9). 1685–1694. 123 indexed citations
9.
Roman, Viviana, et al.. (2000). Expression of a functional inducible nitric oxide synthase in hairy cell leukaemia and ESKOL cell line. Leukemia. 14(4). 696–705. 20 indexed citations
10.
Aubry, Jean‐Pierre, Nathalie Dugas, Sybille Lecoanet-Henchoz, et al.. (1997). The 25-kDa soluble CD23 activates type III constitutive nitric oxide-synthase activity via CD11b and CD11c expressed by human monocytes. The Journal of Immunology. 159(2). 614–622. 35 indexed citations
11.
Roman, Viviana, Nathalie Dugas, A Abadie, et al.. (1997). Characterization of a constitutive type III nitric oxide synthase in human U937 monocytic cells: stimulation by soluble CD23. Immunology. 91(4). 643–648. 22 indexed citations
12.
Dugas, Nathalie, et al.. (1996). Role of leukotriene B4 in the interleukin‐4‐induced human mononuclear phagocyte activation. Immunology. 88(3). 384–388. 12 indexed citations
13.
Kolb, J.P., et al.. (1995). Role of CD23 in NO production by human monocytic cells. Research in Immunology. 146(9). 684–689. 6 indexed citations
14.
Dugas, Bernard, Nathalie Paul‐Eugène, Kunio Yamaoka, et al.. (1995). IL‐4 induces cAMP and cGMP in human monocytic cells. Mediators of Inflammation. 4(4). 298–305. 6 indexed citations
15.
Vouldoukis, Ioannis, C. R. Fourcade, Nathalie Paul‐Eugène, et al.. (1994). CD23 and IgE expression during the human immune response to cutaneous leishmaniasis : Possible role in monocyte activation. Research in Immunology. 145(1). 17–27. 22 indexed citations
16.
Kolb, J.P., A Abadie, Nathalie Paul‐Eugène, et al.. (1993). Ligation of CD23 triggers cyclic AMP generation in human B lymphocytes. The Journal of Immunology. 150(11). 4798–4809. 31 indexed citations
17.
Paul‐Eugène, Nathalie, Claudine Amirand, F Ouaaz, et al.. (1993). Biochemical and functional alterations induced by CD23 ligation in the human promonocytic cell line U937.. PubMed. 80(3). 424–30. 4 indexed citations
19.
Kolb, J.P., D. Renard, Bernard Dugas, et al.. (1990). Monoclonal anti-CD23 antibodies induce a rise in [Ca2+]i and polyphosphoinositide hydrolysis in human activated B cells. Involvement of a Gp protein.. The Journal of Immunology. 145(2). 429–437. 33 indexed citations
20.
Génot, Elisabeth, Christian Billard, Claire Mathiot, et al.. (1987). Proliferative response of hairy cells to B cell growth factor (BCGF): in vivo inhibition by interferon-alpha and in vitro effects of interferon-alpha, -beta, and -gamma.. PubMed. 1(8). 590–6. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026